Alchemab Is Bringing A New Meaning To Patient-Centered Care

British-Bostonian Biotech Is Working Backwards To Explain Disease Resilience

 
• By Chloe Kent
  
Depiction of an antibody
Alchemab is sequencing patients' B-cells in the hope of finding treatments for serious illnesses • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from In Vivo